Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2000
12/19/2000CA2053206C Monoclonal antibodies against melanoma
12/19/2000CA2026926C Y-chromosome specific polynucleotide probes for prenatal sexing
12/19/2000CA1341158C Octopine t-dna promoters
12/17/2000CA2306055A1 Methods and oligonucleotides for detecting nucleic acid sequence variations
12/17/2000CA2305849A1 Oligonucleotides for amplification and detection of hemochromatosis genes
12/14/2000WO2000075995A1 Chip and method for fitting out a chip comprising a plurality of electrodes
12/14/2000WO2000075669A1 Screening methods for altering circadian rhythm proteins
12/14/2000WO2000075665A1 Early detection of flaviviruses using the ns1 glycoprotein
12/14/2000WO2000075660A1 Methods and compositions for identifying inhibitors of osteoclastic bone reabsorption
12/14/2000WO2000075651A1 Surfaces with reduced electroosmotic flow
12/14/2000WO2000075626A1 Platform for chemical or biological analysis with microbalances, analysis device and method using same
12/14/2000WO2000075376A1 Hepg2 cells stably transfected with hcv
12/14/2000WO2000075375A1 26 human secreted proteins
12/14/2000WO2000075374A1 Solid phase methods for amplifying multiple nucleic acids
12/14/2000WO2000075372A1 A process for preparing peptide nucleic acid probe using polymeric photoacid generator
12/14/2000WO2000075370A1 In vivo selection method for determining inhibitory rna molecules
12/14/2000WO2000075368A2 Method for the synthesis of dna fragments
12/14/2000WO2000075366A2 Transcription-based gene mapping
12/14/2000WO2000075365A2 Compounds and methods to enhance raav transduction
12/14/2000WO2000075362A2 Method for identifying novel transcriptional regulatory proteins
12/14/2000WO2000075359A2 Gene encoding short integuments and uses thereof
12/14/2000WO2000075356A1 Rna polymerase chain reaction
12/14/2000WO2000075354A2 Adenoviral vectors encoding interferon and their use in gene therapy
12/14/2000WO2000075353A1 Compositions and methods useful for production of recombinant viruses which require helper viruses
12/14/2000WO2000075352A2 Hcv/bvdv chimeric genomes and uses thereof
12/14/2000WO2000075351A1 Siv-based packaging-defficient vectors
12/14/2000WO2000075350A2 Nucleic acid sequences encoding proteins involved in fatty acid beta-oxidation and methods of use
12/14/2000WO2000075349A1 Method for conferring resistance to crown gall disease
12/14/2000WO2000075348A1 Recombinant anti-cd40 antibody and uses thereof
12/14/2000WO2000075347A2 Tet repressor-based transcriptional regulatory proteins
12/14/2000WO2000075346A1 Fusion proteins comprising a fragment of a chaperon polypeptide
12/14/2000WO2000075345A1 Recombinant fusion protein, (vaccine) composition containing the same and method for the production thereof
12/14/2000WO2000075344A1 Pectate lyase fusion for expression and secretion of polypeptides
12/14/2000WO2000075343A2 ENGINEERING β-KETOACYL ACP SYNTHASE FOR NOVEL SUBSTRATE SPECIFICITY
12/14/2000WO2000075342A1 Novel plasmid vector
12/14/2000WO2000075341A1 Δ6-acetylenase and δ6-desaturase from ceratodon purpureus
12/14/2000WO2000075340A2 Magnesium chelatase
12/14/2000WO2000075339A1 Substrate trapping protein tyrosine phosphatases
12/14/2000WO2000075338A2 CLONED GENONE OF INFECTIOUS HEPATITIS C VIRUS OF GENOTYPE 2a AND USES THEREOF
12/14/2000WO2000075337A1 INFECTIOUS cDNA CLONE OF GB VIRUS B AND USES THEREOF
12/14/2000WO2000075336A2 Polyepitopic proteinic fragments of e6 and e7 hpv proteins, production and use thereof in vaccines
12/14/2000WO2000075335A2 Bacteriophage rm 378 of a thermophilic host organism
12/14/2000WO2000075334A1 Apoptosis inhibition by adenovirus e3/6.7k
12/14/2000WO2000075333A1 Streptavidin expressed gene fusions and methods of use thereof
12/14/2000WO2000075332A2 USE OF THE REGULATORY SUBUNIT OF THE CAMP DEPENDENT PROTEIN KINASE (PKA) FROM DICTYOSTELIUM FOR cAMP MEASUREMENTS
12/14/2000WO2000075331A1 Compositions affecting programmed cell death and their use in the modification of forestry plant development
12/14/2000WO2000075330A1 Use of the bnm3 transcriptional activator to control plant embryogenesis and regeneration processes
12/14/2000WO2000075329A1 Targeted angiogenesis
12/14/2000WO2000075328A1 Human sel-10 polypeptides and polynucleotides that encode them
12/14/2000WO2000075327A1 Methods and compositions for inhibiting neoplastic cell growth
12/14/2000WO2000075326A1 Suppressor of cytokine signaling (socs)-3 promoter and methods for its use
12/14/2000WO2000075325A1 Lifeguard (lfg) polynucleotides and polypeptides and methods of use thereof
12/14/2000WO2000075324A2 Recombinant prion-like genes and proteins and materials and methods comprising same
12/14/2000WO2000075323A1 Tek antagonists
12/14/2000WO2000075322A1 Insect monoamine transporter and methods of use thereof
12/14/2000WO2000075321A2 Polynucleotides and membrane-bound polypeptide encoded thereby
12/14/2000WO2000075320A2 Human genes and proteins encoded thereby
12/14/2000WO2000075319A1 Modified chimeric polypeptides with improved pharmacokinetic properties
12/14/2000WO2000075318A1 Phospholipid transfer protein
12/14/2000WO2000075317A2 Compositions and methods for the treatment of tumor
12/14/2000WO2000075316A1 Methods and compositions for inhibiting neoplastic cell growth
12/14/2000WO2000075315A1 Novel transporter gene expressed in liver
12/14/2000WO2000075314A1 Novel hemopoietin receptor protein nr10
12/14/2000WO2000075313A1 Method for judging rheumatoid arthritis
12/14/2000WO2000075312A1 Cd44 splice variant associated with rheumatoid arthritis
12/14/2000WO2000075311A1 Recombinant nematode nicotinic receptor and uses
12/14/2000WO2000075310A1 Interleukin-1-receptor associated kinase-3 (irak3)
12/14/2000WO2000075309A1 Spliceosome protein and its use
12/14/2000WO2000075308A1 Muteins of bilin-binding protein
12/14/2000WO2000075307A1 Hygromycin tolerance gene and transformed yeast belonging to the genus candida
12/14/2000WO2000075305A2 Candida albicans genes and proteins coded by said genes
12/14/2000WO2000075304A1 Immunostimulant oligonucleotide
12/14/2000WO2000075301A1 Method for predicting binding site structure of gene regulator and apparatus therefor
12/14/2000WO2000075300A2 Methods for manipulating the avian genome
12/14/2000WO2000075299A1 Hybrid yeast-bacteria cloning system and uses thereof
12/14/2000WO2000075295A1 Chemically modified lipolytic enzyme
12/14/2000WO2000075294A1 Glycogenin, glycogenin pseudogenes, and uses thereof to determine risk for developing type 2 diabetes
12/14/2000WO2000075292A1 Herpes simplex virus expressing foreign genes and method for treating cancers therewith
12/14/2000WO2000075289A1 Compositions and methods for targeted gene insertion
12/14/2000WO2000075283A1 Production by yeasts of aspartic proteinases from plant origin with sheep's, cow's, goat's milk, etc. clotting and proteolytic activity
12/14/2000WO2000075279A2 Nucleotide sequences for gene regulation and methods of use thereof
12/14/2000WO2000075278A2 Gene encoding nade, p75ntr-associated cell death executor and uses thereof
12/14/2000WO2000075277A2 A MOLECULAR MARKER BASED ON THE Frk2 (FRUCTOKINASE 2) GENE
12/14/2000WO2000075276A2 Dna detector based on molecular controlled semiconductor resistor
12/14/2000WO2000075190A2 Hybridomas for lung cancer marker and monoclonal antibodies thereof
12/14/2000WO2000075188A1 Method of measuring plasma membrane targeting of glut4
12/14/2000WO2000075187A1 An integrin heterodimer and an alpha subunit thereof
12/14/2000WO2000075181A1 Polyepitopic proteinic fragments of the hiv nef protein, production and use thereof in vaccinations
12/14/2000WO2000075180A2 Peptides for vaccinating against human cmv
12/14/2000WO2000075175A1 Peptide having for fibrinogen fragment e activity, analogs, antibodies and uses thereof
12/14/2000WO2000075170A1 Mutant fatty acid desaturase and methods for directed mutagenesis
12/14/2000WO2000075164A1 COMPOSITIONS AND METHODS FOR DRUG DELIVERY USING pH SENSITIVE MOLECULES
12/14/2000WO2000075163A1 Angiogenic proteins and uses thereof
12/14/2000WO2000075162A1 A compound containing a labile disulfide bond
12/14/2000WO2000075159A1 FUNGAL EXO-β 1,3 GLUCOSIDASE ENCODING DNA MOLECULE AND ITS USE IN CONTROLLING FUNGI IN PLANTS
12/14/2000WO2000074741A2 Biological joint construct
12/14/2000WO2000074725A1 Identification of compounds that modify transcriptional responses to hypoxia
12/14/2000WO2000074724A2 Conjugates comprising cytokines and nucleic acids for treating proliferating cells
12/14/2000WO2000074723A2 Methods for the gene therapy of benign prostatic hyperplasia and medical agents therefore
12/14/2000WO2000074722A2 Modification of biological elements
1 ... 3140 3141 3142 3143 3144 3145 3146 3147 3148 3149 3150 3151 3152 3153 3154 3155 3156 3157 3158 3159 3160 ... 4023